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BACKGROUND Iatrogenic dissection (ICAD) of the left main coronary
artery (LM) and proximal LAD (p-LAD) during percutaneous coronary
intervention (PCI) is a much dreaded complication; however, little is
known regarding the long-term clinical outcome of these patients.
The aim of the present study was to evaluate the short- and long-term
clinical outcome of ICAD involving LM and p-LAD during PCI and to
compare it to those of non-LM dissections.
METHODS All consecutive ICAD during PCI were identiﬁed using
National Heart Lung and Blood Institute diagnostic criteria. The
cohort was divided into LM and p-LAD group and all other coronary
arteries as non-LM group. Demographic clinical, procedural and
follow-up data were collected. These patients were prospectively
followed for a 3-year period for the outcomes of major adverse car-
diovascular events (MACE) and cardiac death.
RESULTS A total of 1132 ICAD events were identiﬁed, of which 27%
occurred in the LM group. Lower incidence of LM ICAD was seen
during primary PCI (9 vs. 23, p¼0.04). Right coronary was the
commonest artery in the non-LM group. As a result of the dissec-
tion there was one death during the procedure in the non-LM
group. Forty-four patients (8 in the LM-P-LAD group) underwent
urgent coronary artery bypass grafting. In-hospital outcomes were
favorable with only 1 patient developing subacute stent thrombosis
in the non LM group and with 1 cardiac death in the non-LM group.
In the non-LM group, 4 patients underwent target vessel PCI. There
was no signiﬁcant difference in the rates of MACE or cardiac death
between the LM /p-LAD and non–LM group at 30 days, 1, 2 and
3 years.
CONCLUSIONS ICAD involving LM and p-LAD is a rare complication
of PCI procedure. Although considered a serious complication of PCI,
it does not necessarily portend a worse early or long-term clinical
outcome when compared to non-LM dissections.CATEGORIES CORONARY: Complications
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BACKGROUND Recently, the 1-year clinical and 9-month angiographic
results of The TRYTON (Prospective, Single Blind, Randomized Controlled
Study to Evaluate the Safety & Effectiveness of the Tryton Side Branch
Stent Used With DES in Treatment of de Novo Bifurcation Lesions in the
Main Branch & Side Branch in Native Coronaries) IDE trial were reported,
showing no difference in overall target vessel failure (TVF) using the
TRYTON (TrytonMedical Inc., Durham, North Carolina) stent compared to
the standard provisional approach. The lack of beneﬁt with the TRYTON
dedicated bifurcation stent strategy was predominantly driven by an
excess of small peri-proceduralmyocardial infarctions (MI) in the TRYTON
group, especially in smaller side branches (<2.5 mm diameter by visual
estimate). A subset analysis of the TRYTON trial examining the outcomes
in the larger side branches, indicated possible beneﬁt of TRYTON on both
angiographic and clinical outcomes. Therefore, the role of a dedicated
bifurcation stent strategy for the treatment of some complex bifurcation
lesions remains to be answered. Moreover, the long term clinical outcome
of the TRYTONdedicated bare-metal stent is unknown.Herewe report the
2-year clinical follow-up of the TRYTON IDE trial, including special atten-
tion to the large side branch cohort.
METHODS The TRYTON IDE trial randomly assigned patients with
true bifurcation lesions to a main vessel stent plus provisional stent-
ing or the bifurcation stent. The clinical primary endpoint was TVF
(cardiac death, target vessel MI, and target vessel revascularization).
The primary endpoint and its components will be reported and
compared between both strategies.
RESULTS The complete results will be available at the time of the
presentation.
CONCLUSIONS The conclusions will be available at the time of the
presentation.
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BACKGROUND Robotic PCI can potentially address the occupational
hazards associated with interventional cardiology, addressing both
the orthopedic and radiation associated risks. The safety and feasi-
bility of robotically assisted percutaneous coronary intervention (PCI)
